Poznámky k epizodě
In this episode of The Connect Current, host James Zanewicz is joined by Courtney Young, PhD, Co-founder and CEO of MyoGene Bio, one of Connect's 2026 Cool Companies. MyoGene Bio is developing MyoDys45-55, an AAV-delivered CRISPR gene editing therapy for Duchenne muscular dystrophy, a rare and devastating muscle wasting disease with no cure. Courtney traces her path from a high school moment, when her cousin Christopher was diagnosed with Duchenne, through graduate research at UCLA to co-founding MyoGene Bio alongside her advisors, Dr. Melissa Spencer and Dr. April Pyle. The conversation…
Web: theconnectcurrent.org

